Table 2 QLQ scores from start to end of treatment
From: IPM chemotherapy in cytokine refractory renal cell cancer
No. of patients | Change in | ||||
|---|---|---|---|---|---|
Better | Same | Worse | score | ||
QOL | Quality of life | 3 | 3 | 8 | −8.5 |
PF | Physical function | 2 | 10 | 2 | 0 |
RF | Role function | 6 | 6 | 0 | 0 |
EF | Emotional function | 5 | 6 | 3 | 0 |
CF | Control function | 1 | 7 | 6 | 0 |
SF | Social function | 3 | 6 | 5 | 0 |
FA | Fatigue | 1 | 5 | 8 | +11.0 |
NV | Nausea and vomiting | 2 | 5 | 7 | +8.5 |
PA | Pain | 3 | 8 | 3 | 0 |
DY | Dyspnoea | 1 | 7 | 6 | 0 |
SL | Insomnia | 2 | 5 | 7 | +16.5 |
AP | Appetite | 1 | 7 | 6 | 0 |
CO | Constipation | 2 | 9 | 3 | 0 |
DI | Diarrhoea | 1 | 8 | 5 | 0 |
FI | Financial difficulties | 5 | 8 | ||
